Pharma Equity Group (“PEG” or “the Company”) presented a Q4-report marked by advancements in the cli...
Redeye provides a research update on Scandinavian ChemoTech following the Q4 2023 report and the ret...
Cibus announced yesterday evening it has issued a 4-year EUR bond of EUR 80m at Euribor 3m plus 400b...
Brilliant Future, med en kund- och medarbetarundersökningsplattform, ökade nettoomsättningen till 89...
37% y-o-y ARR growth with 118% NRR in Q4 Lifting '24e-'26e ARR by 6-8%, EBITDA largely unchanged New...
Redeye updates its view on Flexion Mobile following its Q4 2023 report.
Redeye views today's contract from Smart Eye as a breakthrough in AIS.
Redeye comments on Sleep Cycle’s Capital Markets Day (CMD), including the revised financial targets.
Pharma Equity Group (“PEG” or “the Company”) published its Year-End report for 2023 on the 20th of M...
The recent scientific paper in Neurotherapeutics discusses the encouraging preclinical studies focus...
Kvartalet i korthet Försäljningen under Q4(23) uppgick till drygt 1 mkr (0) och utgjordes av ersättn...
Redeye comments on MGI’s record sales figures for February, representing an organic growth of 25%, u...
Redeye comments on Flexion Mobile's Q4 2023 report, which aligned with preliminary figures.
Kapsaicinproducenten XP Chemistries har lämnat in sin Feed additive-ansökan till EFSA (European Food...
Eevia Health Plc (”Eevia” or “the Company”) announced on Tuesday, March 19th, that the Company has r...
Redeye leaves a comment following the recently announced updated data from the BEXMAB study with the...
Today’s announcement opens the possibility of international patent protection for DiviTum outside th...
EGM in 3R Petroleum the next step in transformation Over the past year, Maha has continued to transf...
Aspo will receive EUR 34m in cash by divesting two Supramax vessels.
ChargePanel publicerade den 18 mars år 2024 bolagets delårsrapport för det fjärde kvartal 2023.
